CNCR Top Holdings & Constituents
CNCR, offered by Exchange Traded Concepts, holds 76 reported positions across $12.7M in assets. Its largest holdings are Recursion Pharmaceuticals Inc (RXRX) (4.01%), Precigen Inc (PGEN) (3.05%), and Compass Therapeutics Inc (CMPX) (2.99%). The 5 biggest positions account for 15.82% of reported assets. The table below lists every reported holding with its portfolio weight and market value in US dollars — open any constituent to research its own performance.
| Position | Weight | Market Value |
|---|---|---|
RXRX Recursion Pharmaceuticals Inc | 4.01% | $358.28K |
PGEN Precigen Inc | 3.05% | $272.33K |
CMPX Compass Therapeutics Inc | 2.99% | $266.91K |
GNLX Genelux Corp | 2.90% | $259.01K |
SWTX SpringWorks Therapeutics Inc | 2.86% | $255.65K |
Holdings data comes from the latest SEC Form N-PORT-P filing for this fund, covering the reporting period ended Feb 28, 2025. Market values are reported in US dollars, and each weight represents the position's share of reported fund assets. Cash, derivatives, and rounding can mean displayed weights do not total 100%. Funds rebalance and file on a schedule, so this page may not reflect intraday or post-filing changes.